Peer Review reports
From: Targeting Ezh2 could overcome docetaxel resistance in prostate cancer cells
| Original Submission | ||
|---|---|---|
| 19 Mar 2018 | Submitted | Original manuscript |
| 17 Jun 2018 | Reviewed | Reviewer Report - Supreet Agarwal |
| 8 Sep 2018 | Reviewed | Reviewer Report - Reviewer 2 |
| 23 Oct 2018 | Author responded | Author comments - Xiaofu Qiu |
| Resubmission - Version 2 | ||
| 23 Oct 2018 | Submitted | Manuscript version 2 |
| 26 Oct 2018 | Reviewed | Reviewer Report - Supreet Agarwal |
| 11 Nov 2018 | Author responded | Author comments - Xiaofu Qiu |
| Resubmission - Version 3 | ||
| 11 Nov 2018 | Submitted | Manuscript version 3 |
| Publishing | ||
| 16 Dec 2018 | Editorially accepted | |
| 8 Jan 2019 | Article published | 10.1186/s12885-018-5228-2 |
You can find further information about peer review here.